Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
Chandan HealthcareNSE:CHANDAN -4.01%17 Net Margin % is 6.98% as of Dec. 2025, which is 20% above its 10-year median of 5.84. GuruFocus rates NSE:CHANDAN with a GF Score™ of 17/100. The stock has 4 warning signs investors should review. Among 203 Medical Diagnostics & Research companies, Chandan Healthcare ranks better than 73.4% on this metric.
The historical rank and industry rank for Chandan Healthcare's Net Margin % or its related term are showing as below:
NSE:CHANDAN'
s Net Margin % Range Over the Past 10 Years
Min: -0.93 Med: 5.84 Max: 9.64
Current: 8.27
NSE:CHANDAN's Net Margin % is ranked better than 73.4% of 203
companies
in the Medical Diagnostics & Research industry
Industry Median: -2.69
vs NSE:CHANDAN: 8.27
Chandan Healthcare (NSE:CHANDAN) Net Margin % Explanation
Although Net Income and Earnings-per-Share (EPS) are the most widely used parameter in measuring a company's profitability and valuation, it is the least reliable. The reason is that reported earnings can be manipulated easily by adjusting any numbers such as Depreciation, Depletion and Amotorization and non-recurring items.
But the long term trend of the net margin is a good indicator of the competitiveness and health of the business.
Chandan Healthcare Net Margin % Related Terms
Chandan Healthcare Net Margin % Historical Data
* Premium members only.
The historical data trend for Chandan Healthcare's Net Margin % can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
NSE:CHANDAN vs TMO, DHR, IDXX: Net Margin % Comparison
For the Diagnostics & Research subindustry, Chandan Healthcare's Net Margin %, along with its competitors' market caps and Net Margin % data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Chandan Healthcare Net Margin % vs Medical Diagnostics & Research Industry
For the Medical Diagnostics & Research industry and Healthcare sector, Chandan Healthcare's Net Margin % distribution charts can be found below:
* The bar in red indicates where Chandan Healthcare's Net Margin % falls into.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Chandan Healthcare (NSE:CHANDAN) has a Net Margin % of 6.98% as of Dec. 2025. Net margin is the ratio of total net income to net sales. View historical data on Chandan Healthcare and its competitors. This is 20% above median its historical median of 5.84. According to the industry distribution chart, Chandan Healthcare ranks #54 out of 203 companies in the Medical Diagnostics & Research industry, placing it in the top 26.6%.
Is Chandan Healthcare's Net Margin % too high?
Chandan Healthcare's current Net Margin % of 6.98% is 20% above median its 10-year median of 5.84. Based on the distribution chart, Chandan Healthcare ranks #54 out of 203 companies in the Medical Diagnostics & Research industry, which is above the industry midpoint. Overall, Chandan Healthcare has a GF Score™ of 17/100, reflecting its overall financial health beyond just this single metric.
How does Chandan Healthcare's Net Margin % compare to TMO and DHR?
According to the Medical Diagnostics & Research industry distribution chart, Chandan Healthcare ranks #54 out of 203 companies for Net Margin %. This puts Chandan Healthcare in the upper half of its industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Net Margin % for a Medical Diagnostics & Research company?
A good Net Margin % depends on the Medical Diagnostics & Research industry context. However, Net Margin % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Net Margin % mean?
A high Net Margin % can signal that a stock is expensive relative to its fundamentals. Net margin is the ratio of total net income to net sales. View historical data on Chandan Healthcare and its competitors. Chandan Healthcare's current Net Margin % is 6.98%, which is 20% above median its own 10-year median of 5.84. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Chandan Healthcare stock overvalued right now?
Chandan Healthcare (NSE:CHANDAN) has a current Net Margin % of 6.98%. The current Net Margin % is 6.98%, which is 20% above median its 10-year median of 5.84. Chandan Healthcare's overall GF Score™ is 17/100 with 4 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Net Margin % calculated?
Net Margin % is calculated from a company's financial statements. For Chandan Healthcare (NSE:CHANDAN), the current Net Margin % is 6.98% as of Dec. 2025. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Chandan Healthcare Ltd operates laboratories that offer comprehensive pathological investigations. Its services encompass biochemistry, hematology, histopathology, microbiology, and immunology. Additionally, it provide an extensive array of radiology services, including CT scans, X-rays, and MRIs. The company operates single reportable business segment that is Diagnostics Services.
17GF Score
Get the complete analysis for NSE:CHANDAN
Net Margin % is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
NSE:CHANDAN has been successfully added to your 
